Filing Flows › ENvue Medical (FEED) › Q4 2024
ENvue Medical (FEED) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 31, 2025
ENvue Medical (FEED) reported revenue of $444K for the fourth quarter 2024 (Q4 2024), -62% from a year earlier and +18% from the quarter before. Operating margin was -308.6%, net loss $1.4M (322.3% of revenue).
ENvue Medical, Q4 2024: revenue $444K (-62% year over year), operating margin -308.6%, net loss $1.4M, operating cash flow −$548K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $444K | +18% | -62% |
| Operating profit | −$1.4M | — | — |
| Net earnings | −$1.4M | — | — |
| Operating cash flow | −$548K | — | — |
What changed
Revenue was $444K in Q4 2024, down 62% year over year and up 18% from the previous quarter.
Gross margin was 63.7%, up 1.1 points from a year earlier. Operating costs exceeded revenue by $1.4M, an operating margin of -308.6%. Operating expenses grew 15% against a revenue fall of 62%. The fastest-growing cost line was Research & development (+468%). The quarter ended with a net loss of $1.4M, wider than the previous quarter's $1.0M loss.
Operating cash flow was −$548K. Non-cash charges added back $191K of share-based compensation. Working capital and other items added $692K.
Questions
What was ENvue Medical's revenue in the fourth quarter 2024?
ENvue Medical (FEED) reported revenue of $444K for the fourth quarter 2024 (Q4 2024), -62% from a year earlier and +18% from the quarter before.
Was ENvue Medical profitable in the fourth quarter 2024?
Operating loss was $1.4M (-308.6% of revenue) and net loss $1.4M.
Source: ENvue Medical 10-K on SEC EDGAR.